Skip to content

BELLUS Health Inc.

Delisted

CIK 1259942fmd_0VZJYTK9AGTQWQEFJSZCPYJ34RManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2018 to Dec 31, 2022, 5 periods

Income Statement · Annual · Millions · USD
Line itemFY2019FY2020FY2021FY2022
Total revenues0000
Research and development19235958
Operating income(26)(33)(73)(78)
Interest expense1003
Income before taxes(26)(32)(71)(76)
Income tax expense––(0)0
Net income from continuing operations––(71)(76)
Net income(26)(32)(71)(76)